Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000950170-25-076406
Filing Date
2025-05-22
Accepted
2025-05-22 16:41:53
Documents
1
Period of Report
2025-05-22

Document Format Files

Seq Description Document Type Size
1 4 ownership.html 4  
1 4 ownership.xml 4 3934
  Complete submission text file 0000950170-25-076406.txt   5504
Mailing Address 7 TIMES SQUARE 43RD FLOOR NEW YORK NY 10036
Business Address 7 TIMES SQUARE 43RD FLOOR NEW YORK NY 10036 929-999-4055
Dianthus Therapeutics, Inc. /DE/ (Issuer) CIK: 0001690585 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O MAGENTA THERAPEUTICS, INC. 100 TECHNOLOGY SQUARE, 5TH FLOOR CAMBRIDGE MA 02139
Business Address
McGeorge Anne (Reporting) CIK: 0001779934 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38541 | Film No.: 25977845